| AMD | Age-related macular degeneration |
| ARVO | Association for Research in Vision and Ophthalmology |
| BAK | Benzalkonium chloride |
| BME | Basal medium eagle |
| BW | Body weight |
| CCM | Complete culture medium |
| CNV | Choroidal neovascularization |
| DMSO | Dimethyl sulfoxide |
| DR | Diabetic retinopathy |
| ERK | Extracellular signal-regulated kinase |
| FBS | Fetal bovine serum |
| GLP | Good laboratory practice |
| IGF1 | Insulin like growth factor 1 |
| IGF1R | Insulin like growth factor 1 receptor |
| iNos | Inducible nitric oxide synthase |
| IOP | Intraocular pressure |
| IR | Ischemia-reperfusion |
| l-glu | l-glutamine |
| MTT | 3-(4,5-dimethilthiazol-2-yl)-2,5-dipheniltetrazolium bromide |
| NaMESys | Nanostructured microemulsions system |
| NaMESys-SOR | Nanostructured microemulsions system carrying 0.3% sorafenib tosylate |
| NFκB | Nuclear factor kappa B |
| NZW | New zealand white |
| PDGF | Platelet-derived growth factor receptor-b |
| RVO | Retinal vein occlusion |
| S.T.R.E. | Short time repeated exposure |
| SIRC | Statens seruminstitut rabbit cornea |
| STZ | Streptozotocin |
| TNFα | Tumor necrosis factor-alpha |
| VEGF | Vascular endothelial growth factor |
| VEGFR1 | Vascular endothelial growth factor receptor 1 |
| VEGFR2 | Vascular endothelial growth factor receptor 2 |
| WB | Western blot |